590 research outputs found

    Hematological changes among Beninese motor-bike taxi drivers exposed to benzene by urban air pollution

    Get PDF
    Exposure to high-concentration of benzene in polluted air has been associated with bone marrow deficiency, aplastic anemia and leukemia. However, epidemiological studies have reported conflicting data following human exposure to benzene levels below 1 ppm (that is, 3.2 mg/m3). Therefore we investigated the influence of outdoor air benzene on peripheral blood cells among exposed motor-biketaxi drivers (MBTD) in which specific IgG antibodies against reactive benzene metabolites, such as hydroquinone (HQ) and para-benzoquinone (p-BQ) are identified and quantified for further use as biomarker of exposure. We compared 144 MBTD with 30 unexposed age and sex-matched controls. The mean age ± SD (95% CI) were: MBTD 39.5 ± 7.82 (38.2 - 40.7) and village residents 40.3 ± 10.56 (39.1-43.0). Personal benzene exposure was assessed using GABIE diffusive samplers. The levels of specific IgG antibodies to HQ and p-BQ were determined by ELISA. The peripheral blood cells were counted by an automated analyzer. Benzene, Toluene and Xylene levels were much higher in MBTD in comparison to the control group. Benzene exposure levels ranged from 0.012 to 0.550 ppm in MBTD. Their average exposure level per one week was 0.126±0.206 ppm. Accordingly, MBTD had significantly higher levels of specific IgG antibodies to HQ and p-BQ compared to the controls (p< 0.001). WBC, lymphocytes, eosinophils and platelets were significantly decreased in MBTD, whereas RBC and other blood cell numbers remained unchanged. Total WBC, lymphocytes and eosinophils counts were decreased among exposed MBTD compared to unexposed controls. We suggest the use of these blood parameters together with specific IgG antibodies to HQ and p-BQ as biomarkers in biological monitoring of low level benzene exposure. Larger studies are however required to validate this new approach of health survey in workers exposed to benzene.Key words: Benzene, motor-bike-taxi drivers, specific immune responses, peripheral blood cell count

    Face validity of a proposed tool for staging canine osteoarthritis: Canine OsteoArthritis Staging Tool (COAST)

    Get PDF
    Abstract Osteoarthritis (OA) is a common, progressive degenerative disease of synovial joints. It can develop subsequent to an acquired disorder such as joint trauma but is primarily driven by developmental orthopedic disease in young dogs. Therefore, it is essentially characterised as an early onset but lifelong disease that worsens with age. Early intervention using a multi-modal drug and non-drug approach, with or without surgery as required, has the greatest potential for the most effective management of the disease. Timely implementation of a continuing care plan provides an opportunity to slow the rate of deterioration by reducing the negative impacts of OA-associated pain, encouraging appropriate levels of activity and improving strength and posture. Unfortunately, many dogs are presented to veterinary clinics only when marked behavioural changes are observed and substantial deterioration of the musculoskeletal and somatosensory systems has already occurred. To assist veterinarians with early and stage-specific diagnosis of OA in dogs, the authors present a proposed, practical diagnostic aid called 'COAST' (Canine OsteoArthritis Staging Tool) with face validity. As indicated by the successful implementation of staging systems for other companion animal diseases, it is expected that standardized staging of OA in dogs will help guide disease management plans and improve monitoring. The items used to construct COAST have been developed using consensus opinion of international experts from nine countries, who are actively working in the fields of small animal orthopaedics, anaesthesia and pain management. Further validation (test-retest, discriminatory ability, responsiveness, criterion validation) of the tool under field conditions is now required and the authors invite input

    Sourcing Flexibility, Spot Trading, and Procurement Contract Structure

    Get PDF
    We analyze the structure and pricing of option contracts for an industrial good in the presence of spot trading. We combine the analysis of spot trading and buyers' disparate private valuations for different suppliers' products, and we jointly endogenize the determination of three major dimensions in contract design: (i) sales contracts versus options contracts, (ii) flat-price versus volume-dependent contracts, and (iii) volume discounts versus volume premia. We build a model in which a supplier of an industrial good transacts with a manufacturer who uses the supplier's product to produce an end good with an uncertain demand. We show that, consistent with industry observations, volume-dependent optimal sales contracts always demonstrate volume discounts (i.e., involve concave pricing). However, options are more complex agreements, and optimal option contracts can involve both volume discounts and volume premia. Three major contract structures commonly emerge in optimality. First, if the seller has a high discount rate relative to the buyer and the seller's production costs or the production capacity is low, the optimal contracts tend to be flat-price sales contracts. Second, when the seller has a relatively high discount rate compared to the buyer but production costs or production capacity are high, the optimal contracts are sales contracts with volume discounts. Third, if the buyer's discount rate is high relative to the seller's, then the optimal contracts tend to be volume-dependent options contracts and can involve both volume discounts and volume premia. However, when the seller's production capacity is sufficiently low, it is possible to observe flat-price option contracts. Furthermore, we provide links between production and spot market characteristics, contract design, and efficiency.National Science Foundation (U.S.) (contract CMMI-0758069)National Science Foundation (U.S.) (contract DMI-0245352

    COAST Development Group's international consensus guidelines for the treatment of canine osteoarthritis

    Get PDF
    This report describes consensus guidelines and recommendations for the treatment of canine osteoarthritis (OA) according to the “Canine OsteoArthritis Staging Tool excluding radiography” (COASTeR) stage of OA, by the COAST Development Group. The recommendations are based on evidence-based medicine and clinical experience and are proposed with international relevance in mind. The aim is to provide veterinarians with a practical reference to consolidated information and to support the development of patient-specific OA management protocols and informed treatment choices based on the stage of OA

    Obtaining Fast Service in a Queueing System via Performance-Based Allocation of Demand

    Full text link

    Progress Report on Target Development

    Get PDF
    The present document is the D08 deliverable report of work package 1 (Target Development) from the MEGAPIE TEST project of the 5th European Framework Program. Deliverable D08 is the progress report on the activities performed within WP 1. The due date of this deliverable was the 5th month after the start of the EU project. This coincided with a technical status meeting of the MEGAPIE Initiative, that was held in March 2002 in Bologna (Italy). The content of the present document reflects the status of the MEGAPIE target development at that stage. It gives an overview of the Target Design, the related Design Support activities and the progress of the work done for the safety assessment and licensing of the target
    • …
    corecore